MBP (83-99)

OC(CC[C@H](N)C(N[C@@H](CC(N)=O)C(N1[C@@H](CCC1)C(N[C@@H](C(C)C)C(N[C@@H](C(C)C)C(N[C@H](C(N[C@@H](CC2=CC=CC=C2)C(N[C@H](C(N[C@@H](CCCCN)C(N[C@@H](CC(N)=O)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](C(C)C)C(N[C@@H]([C@H](O)C)C(N3[C@@H](CCC3)C(N[C@@H](CCCNC(N)=N)C(N[C@@H]([C@H](O)C)C(N4[C@@H](CCC4)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CC5=CC=CC=C5)=O)=O)CC6=CN=CN6)=O)=O)=O)=O)=O)=O

[1]Hemmer B, et al. Human T-cell response to myelin basic protein peptide (83-99) : extensive heterogeneity in antigen recognition, function, and phenotype. Neurology.|[2]Katsara M, et al. A double mutation of MBP (83-99) peptide induces IL-4 responses and antagonizes IFN-gamma responses. J Neuroimmunol. 2008 Aug 30;200 (1-2) :77-89.